Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action (Q33327880)

25 July 2017

title

Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action (English)

1 reference

25 July 2017

1 reference

1 reference

Carly Huitema

1

0 references

Lindsay D. Eltis

object named as

Lindsay D Eltis

6

0 references

John Christopher Vederas

object named as

John C Vederas

5

0 references

author name string

Jianmin Zhang

2

1 reference

25 July 2017

Jiang Yin

3

1 reference

25 July 2017

Michael N G James

4

1 reference

25 July 2017

language of work or name

English

0 references

publication date

27 March 2008

1 reference

Bioorganic & Medicinal Chemistry

25 July 2017

published in

1 reference

25 July 2017

volume

16

1 reference

25 July 2017

issue

10

1 reference

25 July 2017

page(s)

5761-5777

1 reference

Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein

25 July 2017

cites work

1 reference

12 December 2020

Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases

1 reference

12 December 2020

Expression and characterization of recombinant hepatitis A virus 3C proteinase

1 reference

12 December 2020

Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors

1 reference

12 December 2020

Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro

1 reference

12 December 2020

In vitro and ex vivo inhibition of hepatitis A virus 3C proteinase by a peptidyl monofluoromethyl ketone.

1 reference

12 December 2020

Identification of a serine hydrolase as a key determinant in the microbial degradation of polychlorinated biphenyls

1 reference

12 December 2020

Synthesis and evaluation of keto-glutamine analogues as inhibitors of hepatitis A virus 3C proteinase

1 reference

12 December 2020

Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site

1 reference

12 December 2020

Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.

1 reference

12 December 2020

Refined X-ray crystallographic structure of the poliovirus 3C gene product

1 reference

12 December 2020

Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction

1 reference

12 December 2020

An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors

1 reference

12 December 2020

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

12 December 2020

The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

Hepatitis A virus 3C proteinase substrate specificity

1 reference

12 December 2020

Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity

1 reference

12 December 2020

Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters

1 reference

12 December 2020

1 reference

12 December 2020

Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase

1 reference

12 December 2020

Serine and threonine beta-lactones: a new class of hepatitis A virus 3C cysteine proteinase inhibitors

1 reference

12 December 2020

Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase

1 reference

12 December 2020

10.1016/J.BMC.2008.03.059

Identifiers

DOI

1 reference

25 July 2017

0 references

1 reference